Walgreens Boots Alliance, a leading global pharmacy-led health and well-being company, has reported its fiscal 2024 second-quarter results. The company experienced a significant increase in sales during the second quarter, with a 6.3 percent year-over-year growth, amounting to $37.1 billion. On a constant currency basis, sales increased by 5.7 percent.
Tim Wentworth, the Chief Executive Officer of Walgreens Boots Alliance, expressed optimism regarding the company’s performance. He highlighted the positive adjusted EBITDA in the first quarter of the U.S. Healthcare division and the continued growth in overall sales. The pharmacy segment, in particular, demonstrated strong execution and contributed to the company’s success. Wentworth emphasized the importance of customer engagement and value in navigating the challenging retail landscape.
Walgreens Boots Alliance remains committed to its goal of achieving $1 billion in cost savings this year. Over the next three months, the company plans to strategically review its portfolio to ensure sustained growth and value delivery. Led by an executive committee known for operational excellence, the dedicated team members are driving progress by identifying growth opportunities, aiming to create long-term value, and undertaking the necessary work to simplify and strengthen the organization.
The first six months of fiscal 2024 saw a remarkable 8.1 percent increase in sales, amounting to $73.8 billion, or 7.2 percent on a constant currency basis. This growth was observed across all segments. In the U.S. Retail Pharmacy segment, second-quarter sales reached $28.9 billion, representing a 4.7 percent increase from the previous year. Comparable sales also rose by 4.8 percent in the same period.
In the International segment, on the other hand, achieved second-quarter sales of $6.0 billion, marking a 6.6 percent increase from the previous year’s quarter. The favorable currency impact of 3.4 percent contributed to this growth. On a constant currency basis, sales increased by 3.2 percent, with the Germany wholesale business growing by 5.3 percent and Boots UK sales increasing by 3.0 percent.
Boots UK experienced a 1.7 percent growth in comparable pharmacy sales compared to the previous year’s quarter. Additionally, comparable retail sales in Boots UK increased by 5.9 percent across all categories, leading to an increase in total retail market share. Boots.com, the online platform, performed exceptionally well, with sales growing by 16.8 percent and accounting for over 17 percent of Boots’ total retail sales.
